🇺🇸 FDA
Patent

US 8093343

Nitric oxide-releasing diazeniumdiolated compounds

granted A61KA61K31/78A61P

Quick answer

US patent 8093343 (Nitric oxide-releasing diazeniumdiolated compounds) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/78, A61P, A61P9/00, A61P9/10